News | News By Subject | News by Disease News By Date | Search News

Multiple sclerosis (MS) News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
This Drug Could Rattle Biogen (BIIB) and Be the Next Billion-Dollar Blockbuster for Celgene (CELG)     2/20/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
3 Reasons That Make Biogen (BIIB) the King of a Crumbling Empire     11/14/2016
Opexa Therapeutics (OPXA) Stock Tanks After Failed MS Trial, Cuts 40% Staff     11/2/2016
Teva (TEVA) Stock Plummets After Two Patents are Invalidated by Mylan (MYL)     8/25/2016
Novartis AG (NVS) Touts Phase III Data for MS Drug Siponimod     8/25/2016
Speedy Review for Genentech (RHHBY)’s OCREVUS, Action Date December 28     6/29/2016
Biogen (BIIB) Loses $8 Billion in Market Value in One Day After Failed Trial     6/8/2016
Biogen (BIIB)'s Stock Falls as MS Drug Fails to Meet Endpoints in Mid-Stage Study     6/7/2016
Why Biogen (BIIB) Needs Yet Another Multiple Sclerosis Drug     6/3/2016
FDA Approves Biogen (BIIB) and AbbVie (ABBV)'s Once-Monthly MS Drug Zinbryta     6/2/2016
MedDay Secures $38.5 Million to Push MS Drug into Phase III Trials     4/8/2016
Bay Area's XenoPort (XNPT) Snags Psoriasis and MS Deal Worth $490 Million+ from Dr. Reddy's Laboratories Ltd. (RDY)     3/28/2016
Roche (RHHBY)'s Multiple Sclerosis Drug Gets Breakthrough Status, Likely to Haunt Biogen (BIIB)     2/18/2016
Teva (TEVA), Active Biotech (BTPC) Stop Higher Doses of Laquinimod in Two Multiple Sclerosis Trials     1/4/2016

News from Around the Web
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer     2/10/2017
Multiple Sclerosis Drug Triggers Severe Adverse Events, Lancet Neurology Reveals     1/20/2017
Celgene (CELG) Could Dethrone Biogen (BIIB) in Multiple Sclerosis     9/29/2016
Brain Inflammation Linked To Depression In MS Patients, King's College London Study     7/8/2016
Poor Sleep And Thinking Problems In MS Patients, University of Michigan Study     6/21/2016
Allergy Med Might Also Fight MS-Linked Eye Damage, UCSF Study     4/14/2016
Binging On Coffee May Cut Your MS Risk, Study Published In BMJ     3/7/2016
Why It Feels So Good To Scratch An Itch, Published In Proceedings Of The Entomological Society Of Washington     2/29/2016
Sun Exposure During Teen Years May Delay Onset Of MS, Copenhagen University Hospital Study     10/8/2015
Genentech (RHHBY) May Have a $5 Billion MS Blockbuster on Its Hands     9/29/2015
Low Vitamin D Linked To MS, McGill University Study     8/27/2015
Drugs Help MS Patients Create New Stem Cells To Replace Lost Brain Cells, Case Western Reserve University Study     4/22/2015
Biogen Idec (BIIB) Tests Use of Wearables to Track MS Patient Activity     3/11/2015
Can Coffee Cut Your MS Risk? Johns Hopkins University Study     3/2/2015
Diet Affects Brain Iron Levels Differently In Men And Women, University at Buffalo Study Shows     1/27/2015

Press Releases
NYU Langone Medical Center Release: Transcranial Direct Current Stimulation Combined With Computer Games At Home Reduces Cognitive Symptoms Of Multiple Sclerosis     2/22/2017
Apitope Announces Positive ATX-MS-1467 Phase IIa Data In Relapsing Multiple Sclerosis     2/21/2017
Apitope Announces Positive ATX-MS-1467 Phase IIa Data In Relapsing Multiple Sclerosis     2/21/2017
Momenta (MNTA) Hit With a Setback After Warning Letter From the FDA     2/20/2017
Celgene (CELG) Announces Positive Results From Phase III SUNBEAM Trial Of Oral Ozanimod In Patients With Relapsing Multiple Sclerosis     2/17/2017
eMD Release: Cladribine Tablets Significantly Reduced Brain Atrophy In Patients With Multiple Sclerosis     2/13/2017
University of Pennsylvania Release: Anti-Inflammatory, Anti-Cell Death Agent A Potential Treatment For Vision Loss Associated With Multiple Sclerosis     2/9/2017
Celgene (CELG) Receives Positive CHMP Opinion To Expand REVLIMID (Lenalidomide) Indication As Monotherapy For The Maintenance Treatment Of Patients With Newly Diagnosed Multiple Myeloma (MM) After Autologous Stem Cell Transplantation     1/27/2017
Siemens Healthineers (SI), Biogen (BIIB) Release: Companies Announce Agreement To Jointly Develop New MRI Tools For Multiple Sclerosis     1/17/2017
New Trial Results Bolster Genentech (RHHBY)'s Chances of New MS Drug Approval     12/22/2016
Bayer (BAY) Announces FDA Acceptance Of Supplemental Biologics License Application For myBETAapp And BETACONNECT Navigator     12/14/2016
RedHill Biopharma (RDHL) Announces Phase IIa 48-Week Final Results Further Supporting Potential Of RHB-104 In Multiple Sclerosis     12/12/2016
Biogen (BIIB) And AbbVie (ABBV) Receive Health Canada Approval Of Once-Monthly ZINBRYTA (Daclizumab Beta) For Multiple Sclerosis     12/9/2016
Perrigo (PRGO) Reviewing Strategic Alternatives for MS Drug Tysabri     11/10/2016
Opexa Therapeutics (OPXA)' Stock Slammed After MS Candidate Flunks Phase II Test     10/28/2016

//-->